Feb 17, 2026 08:00AM
Dec 22, 2025 07:06AM
Nov 25, 2025 12:48AM
Nov 21, 2025 08:01AM
Nov 18, 2025 07:02AM
Nov 12, 2025 07:02AM
Nov 12, 2025 04:57AM Esperion Therapeutics' (ESPR) LDL-Lowering Drug Supported by KOLs - Citizens
Nov 6, 2025 06:31AM
Oct 17, 2025 07:12AM
Oct 17, 2025 06:46AM
Oct 6, 2025 06:48AM
Oct 3, 2025 08:00AM
Sep 22, 2025 06:46AM
Sep 22, 2025 04:24AM Citizens JMP Reiterates Market Outperform Rating on Esperion Therapeutics (ESPR)
Sep 19, 2025 08:02AM
Aug 11, 2025 04:13PM
Aug 5, 2025 06:19AM
Jul 24, 2025 12:48PM
Jul 8, 2025 08:01AM
Jul 1, 2025 08:07AM
Jun 17, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Esperion Therapeutics (ESPR)
Jun 13, 2025 07:18AM
Jun 2, 2025 08:03AM
May 12, 2025 08:03AM
May 8, 2025 06:30AM
May 6, 2025 06:37AM
Apr 25, 2025 06:56AM
Apr 24, 2025 08:03AM Esperion Therapeutics (ESPR) Unveils Promising Research Supporting Lead Development Candidates for Primary Sclerosing Cholangitis (PSC) at R&D Day 2025
Apr 1, 2025 08:03AM
Mar 24, 2025 05:45AM
Mar 20, 2025 08:00AM
Mar 5, 2025 05:28AM
Mar 4, 2025 06:09AM
Mar 3, 2025 08:01AM
Feb 11, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Esperion Therapeutics (ESPR)
Feb 11, 2025 04:13AM
Jan 23, 2025 07:07AM
Jan 16, 2025 10:28AM
Dec 18, 2024 07:01AM
Dec 18, 2024 04:26AM
Dec 17, 2024 06:32AM
Dec 13, 2024 06:15AM Esperion Therapeutics (ESPR) Announces $210M Convertible Debt Financing
Dec 12, 2024 08:01AM
Dec 3, 2024 07:02AM
Dec 2, 2024 08:01AM
Nov 26, 2024 08:00AM
Oct 3, 2024 06:58AM
Oct 2, 2024 08:01AM
Sep 3, 2024 08:10AM Esperion (ESPR) Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL and NEXLIZET
Aug 12, 2024 06:06AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All